Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.
Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.
Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.
Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.
Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology and services, has been recognized as a leader in the 2024 Frost Radar™: US Population Health Management report by Frost & Sullivan. The company was praised for its innovative Population Health suite, which offers financial and quality benchmarking tools, administrative support, and advanced analytics.
Frost & Sullivan analysts evaluated over 50 US companies in the PHM market based on their innovation and growth strategies. Health Catalyst was highlighted for revolutionizing third-party PHM IT initiatives with custom configurations, a pre-built rules engine, and superior data management capabilities.
CEO Dan Burton emphasized the company's commitment to addressing healthcare challenges through innovation and client-centric solutions, contributing to value-based care. The report also noted Health Catalyst's strategic acquisitions of Carevive and Lumeon, enhancing its oncology care management and patient communication capabilities.
Industry Analyst Sagar Mukhekar commended Health Catalyst's balanced focus on growth and innovation, customized solutions, and superior data management, positioning it as a leader in the PHM market. The company's expansion into underserved segments further solidifies its leadership.
Health Catalyst (HCAT) has announced a strategic partnership with Databricks to enhance healthcare data sharing and analytics. The collaboration integrates Health Catalyst's Ignite™ platform with Databricks' Delta Sharing technology, creating a configurable solution specifically designed for healthcare organizations.
The partnership combines Health Catalyst's healthcare intelligence, including clinical, financial, operational, and regulatory expertise, with Databricks' technical infrastructure optimized for high-scale data processing. The joint solution leverages healthcare-specific data models and advanced analytics, enabling secure cross-platform data sharing across clouds and regions.
This integration aims to help healthcare organizations accelerate insights and access healthcare-ready data without building complex solutions from scratch, ultimately focusing on improving outcomes and operational efficiency.
Health Catalyst (HCAT) has announced a definitive agreement to acquire Upfront Healthcare Services, a next-generation patient engagement platform provider. The acquisition, expected to close in Q1 2025, will be funded through a mix of cash and stock.
The integration aims to combine Upfront's patient acquisition and scheduling expertise with Health Catalyst's existing patient engagement portfolio, including Twistle Patient Engagement and Lumeon Care Orchestration platform. Upfront's technology analyzes clinical, sociodemographic, and patient-reported data to guide patients to needed care, helping providers reengage patients, promote appointment attendance, and improve care transitions.
The merger will integrate with Health Catalyst Ignite™ Data and Analytics to enhance healthcare clients' ability to provide optimal patient care, focusing on optimizing access, improving care transitions, and closing care gaps.
Health Catalyst (Nasdaq: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's executive team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will be present.
The company's presentation is scheduled for Wednesday, January 15, 2025, at 10:30 am PT. Investors and interested parties can access the webcast and presentation materials through Health Catalyst's investor relations website at https://ir.healthcatalyst.com.
Health Catalyst (HCAT) announced the launch of an AI-powered version of BluePrint Protect™, following their agreement to acquire Intraprise Health. The platform helps healthcare organizations screen cybersecurity risks through third parties. The new AI-powered capability automates vendor security assessments, evaluation, and risk tracking, making the process more efficient and cost-effective.
The platform received the highest rating in a KLAS Emerging Company Spotlight Report with A+ scores across multiple categories. Key features include automated risk workflows, enhanced risk visibility through intuitive dashboards, customizable solutions, and compatibility with third-party products.
Health Catalyst (HCAT) has announced its leadership team's participation in three major upcoming investor conferences in December 2024. The schedule includes appearances at:
- The Citi 2024 Global Healthcare Conference in Miami on December 3 at 2:30 pm ET
- The 7th Annual Evercore HealthCONx Conference in Miami on December 4 at 2:10 pm ET
- The 36th Annual Piper Sandler Healthcare Conference in New York on December 5 at 12:30 pm ET
Health Catalyst (Nasdaq: HCAT) announced its participation in the upcoming Stephens Annual Investment Conference in Nashville. The company's leadership team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will take part in a fireside chat scheduled for Wednesday, November 20, 2024, at 1:00 pm CT.
Health Catalyst (Nasdaq: HCAT) has signed a definitive agreement to acquire Intraprise Health, a top-rated cybersecurity provider. This strategic acquisition, expected to close in Q4 2024, aims to enhance Health Catalyst's cybersecurity and risk management offerings. Intraprise, recognized for its leading position in KLAS Research's 2024 Cybersecurity Survey, will integrate its end-to-end cybersecurity risk management platform with Health Catalyst's data and analytics technology. The merger is anticipated to improve healthcare data protection, enhance analytic capabilities, and support industry security standards. The acquisition is funded through a mix of cash and stock, with further details available in Health Catalyst's Form 8-K filed with the SEC on November 6, 2024.
Health Catalyst (Nasdaq: HCAT), a prominent provider of data and analytics technology for healthcare organizations, announced the appointment of Dr. Jill Hoggard Green to its Board of Directors and Compensation Committee, effective December 1, 2024. Dr. Green, former CEO of The Queen's Health Systems, brings 39 years of healthcare leadership experience. She has been recognized as one of Modern Healthcare's Top 25 COOs and Becker's Top 130 Women Leaders in Healthcare. Dr. Green has held significant roles at Mission Health, Peace Health, and Intermountain Healthcare. Her extensive background in patient care and healthcare management is expected to enhance Health Catalyst's mission of delivering data-informed healthcare improvements. CEO Dan Burton expressed excitement about her anticipated contributions to the company's growth and impact.
Health Catalyst (Nasdaq: HCAT) has partnered with CyncHealth, Iowa's statewide health information exchange (HIE), to enhance health data management. This collaboration will leverage Health Catalyst's Ninja Universe, a cloud-native platform, to improve the quality and timeliness of patient health information shared among healthcare providers. By utilizing Health Catalyst's data and analytics, CyncHealth aims to deliver more accurate and secure Continuity of Care Documents (CCDs), facilitating better-coordinated care. Dr. Jaime Bland, CEO of CyncHealth, highlighted the importance of this partnership in advancing healthcare interoperability in Iowa, while Dan Burton, CEO of Health Catalyst, emphasized the positive impact on patient and provider experiences statewide.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
